The drugmaker’s U.S. plans comes on the heels of a rough quarter, with lower vaccine demand driving down Q3 sales by 15% year ...

“I definitely didn’t foresee that there’ll be so many fires to put out,” says the head of HR at BASF. “There’s a lot of ...

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and ...

Enormous Brands has appointed Joy Chauhan as Fractional Chief Marketing Officer (CMO). A relatively new approach in the ...

Concluded targeted enrollment of Phase 3 INDIGO trial evaluating obexelimab for the treatment of Immunoglobulin G4-Related ...

ASHG welcomed eight 2024–2026 Human Genetics Scholars who are recognized for their accomplishments and commitment to fostering DEI in human genetics and genomics.

There’s no better time to be alive, only if we can learn to thrive amidst constant change and disruption” muses health tech ...

Anti-abortion groups plan to unveil a sprawling federal and state strategy today that would undermine the procedure’s protections enacted by ballot measure in nearly a dozen states over the past two ...

Thousands of apartments have been added — and hundreds taken away — from Greater Philadelphia's pipeline in recent weeks, ...

GSK has shifted towards a global marketing model ... “It then becomes our job to partner with the global teams to operationalise the leader’s vision and how it comes to life.

Fed delivered the widely expected 25 bps rate cut yesterday. A pause in rate cuts can't be ruled out in December. See my ...

What’s an example of a well-executed drug launch? Look no further than Reata’s commercialization of Skyclarys, the first ...